EUVIMEDEUVIMED entdecken
Editorial

Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance

Moubadda Assi, Ismaël Maatouk

Clinical Microbiology and Infection · 2026-07

DOI: 10.1016/j.cmi.2026.06.030 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Microbiology and Infection, 2026-07. Verfasst von Moubadda Assi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Balamand, Beirut, Lebanon. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Health Sciences, University of Balamand, Beirut, Lebanon.
  • School of Medicine, Lebanese American University, Beirut, Lebanon. Electronic address: ismaelmaatouk@gmail.com.

Zitieren

APA

Assi, M., & Maatouk, I. (2026). Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.06.030

Vancouver

Assi M, Maatouk I. Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.06.030

BibTeX
@article{Assi2026,
  author = {Assi, Moubadda and Maatouk, Ismaël},
  title = {Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  doi = {10.1016/j.cmi.2026.06.030}
}
Kostenlos starten →